EUVIMEDEUVIMED entdecken
Open Access

Vestibular Dysfunction as a Novel Presentation of Middle Ear Neuroendocrine Tumor

Amor Niksic, Rance Jt Fujiwara, Brandon Isaacson

Journal of Neurological Surgery Reports · 01.01.2026 · 87 (01) · e41-e45

DOI: 10.1055/a-2823-9080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Reports, erschienen am 01.01.2026. Verfasst von Amor Niksic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to contribute to the sparse literature on middle ear neuroendocrine tumors (MeNETs) by detailing a unique case of MeNET-associated cochlear–vestibular dysfunction and outlining diagnostic, therapeutic, and follow-up considerations.

Design

A single-patient case report.

Setting

A tertiary academic referral center. Participant A 40-year-old male presenting with profound left sensorineural hearing loss (SNHL), left vestibular hypofunction, and a middle ear mass. Main Outcome Measures Histopathologic confirmation of MeNET, radiological identification of residual disease, postoperative symptom progression, and rehabilitation outcome.

Results

Clinical evaluation, imaging, and histopathology confirmed the diagnosis of MeNET. Immunohistochemistry revealed positivity for chromogranin, synaptophysin, insulinoma-associated protein 1 (INSM1), cytokeratin mouse monoclonal antibody (CAM 5.2). An endoscopic middle ear exploration with tympanoplasty and canalplasty was performed, followed by vestibular rehabilitation. Surveillance with DOTA-Tyr3-octreotate PET/MRI identified residual disease, leading to a revision mastoidectomy. The patient experienced persistent imbalance postoperatively, requiring vestibular rehabilitation, and profound SNHL, for which a hearing aid evaluation was recommended.

Conclusions

This case represents the first report of MeNET-associated cochlear–vestibular dysfunction. The significance of this report lies in the unique clinical presentation, the role of advanced imaging for surveillance, and the need for revision mastoidectomy following an initial endoscopic approach. This report discusses the challenges in achieving complete tumor clearance and emphasizes the need for continued case documentation and research into adjunctive therapies.

Schlagwörter

Stichwörter der Autor:innen

DOTA-TATE PET/MRIcochlear–vestibular dysfunctionmiddle ear neuroendocrine tumor

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States.

Zitieren

APA

Niksic, A., Fujiwara, R. J., & Isaacson, B. (2026). Vestibular Dysfunction as a Novel Presentation of Middle Ear Neuroendocrine Tumor. Journal of Neurological Surgery Reports, 87(01), e41-e45. https://doi.org/10.1055/a-2823-9080

Vancouver

Niksic A, Fujiwara RJ, Isaacson B. Vestibular Dysfunction as a Novel Presentation of Middle Ear Neuroendocrine Tumor. Journal of Neurological Surgery Reports. 2026;87(01):e41-e45. doi:10.1055/a-2823-9080

BibTeX
@article{Niksic2026,
  author = {Niksic, Amor and Fujiwara, Rance Jt and Isaacson, Brandon},
  title = {Vestibular Dysfunction as a Novel Presentation of Middle Ear Neuroendocrine Tumor},
  journal = {Journal of Neurological Surgery Reports},
  year = {2026},
  volume = {87},
  number = {01},
  pages = {e41--e45},
  doi = {10.1055/a-2823-9080}
}
Kostenlos starten →